Abstract
China has a large population and a high prevalence of chronic kidney disease (CKD). The increasing incidence of obesity and type 2 diabetes mellitus, coupled with an ageing population, will exacerbate the burden of CKD unless effective control and prevention strategies are implemented. The unmet challenges of managing the growing number of patients with end-stage renal disease (ESRD) in China are reflected by the lower rate of patients receiving dialysis relative to many Western countries, owing to a lack of financial and clinical resources, and inequalities in access to health care across regions and populations. The feasibility of expanding peritoneal dialysis is being examined, and ongoing health-care reforms provide an invaluable opportunity to improve the status and quality of dialysis for patients with ESRD in China. The Chinese Society of Nephrology (CSN) advocates for efforts focused on preventing CKD coupled with early detection, treatment, and adequate follow-up to reduce mortality and the long-term burden of CKD. In addition, rapid advances in nephrology research, from basic science to clinical epidemiology, as well as broad communication and collaboration between the CSN and other international nephrology societies, will promote the development of nephrology in China.
Key Points
-
China has a high prevalence of chronic kidney disease (CKD); an increasing prevalence of hypertension, obesity and type 2 diabetes mellitus, and an ageing population will exacerbate the burden of CKD
-
The current leading cause of CKD in China is glomerular disease, followed by diabetic nephropathy, and hypertension; IgA nephropathy is the most common glomerular disease
-
The proportion of patients with end-stage renal disease receiving dialysis is low owing to a lack of financial and clinical resources and inequalities in health-care access
-
The feasibility of expanding peritoneal dialysis, over more expensive haemodialysis, is currently has being examined
-
Ongoing health-care reform in China will increase the prevalence of dialysis and improve long-term outcomes for patients with CKD
-
The Chinese Society of Nephrology advocates for improved patient care, education and research; collaboration with international nephrology societies will promote the development of nephrology in China
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yang, G. et al. Emergence of chronic non-communicable diseases in China. Lancet 372, 1697–1705 (2008).
Human Development Unit, East Asia and Pacific Region. Towards a healthy and harmonious life in China: stemming the rising tide of non-communicable disease. WorldBank.org [online], (2011).
Liu, L. S. 2010 Chinese guidelines for the management of hypertension [Chinese]. Zhonghua Xin Xue Guan Bing Za Zhi 39, 579–615 (2011).
Shen, J., Goyal, A. & Sperling, L. The emerging epidemic of obesity, diabetes, and the metabolic syndrome in China. Cardiol. Res. Pract. 2012, 178675 (2012).
Yang, W. et al. Prevalence of diabetes among men and women in China. N. Engl. J. Med. 362, 1090–1101 (2010).
Feng, Z., Liu, C., Guan, X. & Mor, V. China's rapidly aging population creates policy challenges in shaping a viable long-term care system. Health Aff. (Millwood) 31, 2764–2773 (2012).
Zhang, L. et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379, 815–822 (2012).
Coresh, J. et al. Prevalence of chronic kidney disease in the United States. JAMA 298, 2038–2047 (2007).
Hallan, S. I. et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J. Am. Soc. Nephrol. 17, 2275–2284 (2006).
Cai, G. & Chen, X. Etiology, comorbidity and factors associated with renal function decline in chinese chronic kidney disease patients. J. Am. Soc. Nephrol. 22, 183A–184A (2011).
United States Renal Data System. 2012 USRDS Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States. United States Renal Data System [online], (2012).
Gilg, J., Castledine, C., Fogarty, D. & Feest, T. UK Renal Registry 13th Annual Report (December 2010): Chapter 1: UK RRT incidence in 2009: national and centre-specific analyses. Nephron Clin. Pract. 119 (Suppl. 2), c1–c25 (2011).
Cao, Y., Li, W., Yang, G., Liu, Y. & Li, X. Diabetes and hypertension have become leading causes of CKD in Chinese elderly patients: a comparison between 1990–1991 and 2009–2010. Int. Urol. Nephrol. 44, 1269–1276 (2012).
Ho, Y. W., et al. Hong Kong Renal Registry Report 2010. Hong Kong J. Nephrol. 12, 81–98 (2010).
Hwang, S. J., Tsai, J. C. & Chen, H. C. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton) 15 (Suppl. 2), 3–9 (2010).
Zhou, F. D., Zhao, M. H., Zou, W. Z., Liu, G. & Wang, H. The changing spectrum of primary glomerular diseases within 15 years: a survey of 3,331 patients in a single Chinese centre. Nephrol. Dial. Transplant. 24, 870–876 (2009).
Li, L. S. & Liu, Z. H. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 66, 920–923 (2004).
White, S. L., Chadban, S. J., Jan, S., Chapman, J. R. & Cass, A. How can we achieve global equity in provision of renal replacement therapy? Bull. World Health Organ. 86, 229–237 (2008).
Zuo, L. & Wang, M. Current burden and probable increasing incidence of ESRD in China. Clin. Nephrol. 74 (Suppl. 1), S20–S22 (2010).
United States Renal Data System. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Chapter 12: International comparisons. United States Renal Data System [online], (2012).
Cheng, X. et al. Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. Nephrol. Dial. Transplant. 28, 724–732 (2012).
United States Renal Data System. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Chapter 5: Mortality. [online], (2012).
Xie, F. et al. Design and implementation of the first nationwide, web-based Chinese Renal Data System (CNRDS). BMC Med. Inform. Decis. Mak. 12, 11 (2012).
Zhang, Z. Z. & Zhao, K. The report of dialysis assessment and payment for end-stage renal disease in China. National Health Development Research Center (2011).
The Chinese Society of Nephrology. A national survey of nephrologists in clinical practice [Chinese; online], (2013).
Fulton, B. D. et al. Health workforce skill mix and task shifting in low income countries: a review of recent evidence. Hum. Resour. Health 9, 1 (2011).
Murugan, R. & Kellum, J. A. Acute kidney injury: what's the prognosis? Nat. Rev. Nephrol. 7, 209–217 (2011).
Fang, Y. et al. Acute kidney injury in a Chinese hospitalized population. Blood Purif. 30, 120–126 (2010).
Fang, Y. et al. Survey of acute kidney injury in hospitalized patients [Chinese]. Chin. J. Nephrol. 23, 417–421 (2007).
Lu, R. H. et al. The incidence and risk factors associated with prognosis of acute kidney injury in hospitalized patients [Chinese]. Chin. J. Nephrol. 28, 194–200 (2012).
Wen, J. et al. Hospital-acquired acute kidney injury in Chinese very elderly persons. J. Nephrol. 26, 572–579 (2013).
Gong, Y., Zhang, F., Ding, F. & Gu, Y. Elderly patients with acute kidney injury (AKI): clinical features and risk factors for mortality. Arch. Gerontol. Geriatr. 54, e47–e51 (2012).
Che, M. et al. Prevalence of acute kidney injury following cardiac surgery and related risk factors in Chinese patients. Nephron Clin. Pract. 117, c305–c311 (2011).
Wang, Y. N., Cheng, H., Yue, T. & Chen, Y. P. Derivation and validation of a prediction score for acute kidney injury in patients hospitalized with acute heart failure in a Chinese cohort. Nephrology (Carlton) 18, 489–496 (2013).
Zhou, J., Yang, L., Zhang, K., Liu, Y. & Fu, P. Risk factors for the prognosis of acute kidney injury under the Acute Kidney Injury Network definition: a retrospective, multicenter study in critically ill patients. Nephrology (Carlton) 17, 330–337 (2012).
Che, M. L. et al. Analysis of drug-induced acute renal failure in Shanghai [Chinese]. Zhonghua Yi Xue Za Zhi 89, 744–749 (2009).
Liao, X. H. et al. Etiology and prognosis of inpatients with acute kidney injury [Chinese]. Chongqing Med. 39, 1250–1253 (2010).
Akcan-Arikan, A. et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 71, 1028–1035 (2007).
Mehta, R. L. et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit. Care 11, R31 (2007).
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. Suppl. 2, 1–138 (2012).
Huang, J. et al. A pilot programme of organ donation after cardiac death in China. Lancet 379, 862–865 (2012).
The database center of the Chinese scientific registry of kidney transplantation. Kidney transplantation in China: An overview (2012) [Chinese; online], (2012).
Huang, J., Mao, Y. & Millis, J. M. Government policy and organ transplantation in China. Lancet 372, 1937–1938 (2008).
Shi, B. Y. & Chen, L. P. Regulation of organ transplantation in China: difficult exploration and slow advance. JAMA 306, 434–435 (2011).
Meng, Q. et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet 379, 805–814 (2012).
Yip, W. C. et al. Early appraisal of China's huge and complex health-care reforms. Lancet 379, 833–842 (2012).
Speech of Vice-Premier Li Keqiang. As China's healthcare reform deepens, progresses and challenges [Chinese; online], (2011).
Wang, J. P. The subsidy system of major diseases in China [Chinese; online], (2012).
Appel, G. B. et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J. Am. Soc. Nephrol. 20, 1103–1112 (2009).
Dooley, M. A. et al. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N. Engl. J. Med. 365, 1886–1895 (2011).
Cattran, D. C. et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 76, 534–545 (2009).
Coppo, R. et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int. 77, 921–927 (2010).
Zeng, C. H. et al. A multicenter application and evaluation of the Oxford classification of IgA nephropathy in adult chinese patients. Am. J. Kidney Dis. 60, 812–820 (2012).
Sharp Collaborative Group. Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. Am. Heart J. 160, 785–794 (2010).
National Natural Science Foundation. 2001 annual report of the National Natural Science Foundation of China [Chinese; online], (2001).
National Natural Science Foundation. 2012 annual report of the National Natural Science Foundation of China [Chinese; online], (2012).
Li, J. et al. Comparative study of scientific publications in urology and nephrology journals originating from, USA, China and Japan (2001–2010). PLoS ONE 7, e42200 (2012).
Kou, J. et al. Clinical research promotes development of nephrology in China: an analysis of 20 years of scientific publications. Ren. Fail. 34, 472–479 (2012).
Acknowledgements
The author's research was supported by the National Basic Research Program of China (No. 2012CB517600, No. 2012CB517606) and the National Key Technology R&D Program (2011BAI10B04).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
Z-H. Liu is President of the Chinese Society of Nephrology
Rights and permissions
About this article
Cite this article
Liu, ZH. Nephrology in China. Nat Rev Nephrol 9, 523–528 (2013). https://doi.org/10.1038/nrneph.2013.146
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.146
This article is cited by
-
The level of serum albumin is associated with renal prognosis and renal function decline in patients with chronic kidney disease
BMC Nephrology (2023)
-
Coexposure to multiple metals and renal tubular damage: a population-based cross-sectional study in China’s rural regions
Environmental Science and Pollution Research (2023)
-
Value of multiparametric magnetic resonance imaging for evaluating chronic kidney disease and renal fibrosis
European Radiology (2023)
-
Long-term exposure to ambient air pollutants and increased risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease: a retrospective cohort study in Beijing, China
Environmental Science and Pollution Research (2023)
-
Association of albumin, globulin and albumin/globulin ratio with renal injury in type 2 diabetic nephropathy patients
International Journal of Diabetes in Developing Countries (2023)